Noveris Health Sciences is trading at CA$0.08, up 6.67%, most likely due to biotechnology-sector strength.

  • Biotech ETF XBI was up 2.55% during regular trading.
  • No new company-specific announcement was identified for September 18, 2026.
  • The latest reported corporate item was the September 4 annual meeting, announced September 9; the move appears sector-driven rather than linked to fresh Noveris news.